{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/read0019681?format=json",
    "@type": "researchers",
    "rm:user_id": "1000052961",
    "rm:creator_id": "1000052961",
    "rm:creator_type": "myself",
    "rm:created": "2011-05-11T15:00:00Z",
    "rm:modifier_id": "1000052961",
    "rm:modifier_type": "myself",
    "rm:modified": "2024-11-25T02:20:36Z",
    "permalink": "read0019681",
    "family_name": {
        "ja": "平井",
        "ja-Kana": "ヒライ",
        "en": "Hirai"
    },
    "given_name": {
        "ja": "幸恵",
        "ja-Kana": "サチエ",
        "en": "Sachie"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "closed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "札幌医科大学",
                "en": "Sapporo Medical University"
            },
            "section": {
                "ja": "医学部  附属フロンティア医学研究所",
                "en": "Research Institute for Frontier Medicine"
            },
            "display_affiliation": "disclosed",
            "display_job": "closed",
            "rm:institution_code": "1100002000"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "closed",
    "identifiers": {
        "j_global_id": [
            "200901055813539125"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "closed",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901055813539125"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/read0019681/research_interests",
            "@type": "research_interests",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_interests/1618580",
                    "@type": "research_interests",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_interests",
                    "rm:id": "1618580",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2011-05-11T15:00:00Z",
                    "keyword": {
                        "ja": "分子生物学"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0019681/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_areas/1128207",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_areas",
                    "rm:id": "1128207",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2011-05-11T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47060",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "医療薬学",
                        "en": "Clinical pharmacy"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_areas/1128206",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_areas",
                    "rm:id": "1128206",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2011-05-11T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47040",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬理学",
                        "en": "Pharmacology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_areas/1128205",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_areas",
                    "rm:id": "1128205",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2011-05-11T15:00:00Z",
                    "discipline_number": "A189",
                    "item_number": "A47030",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "薬系衛生、生物化学",
                        "en": "Pharmaceuticals - health and biochemistry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0019681/research_experience",
            "@type": "research_experience",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_experience/15541746",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_experience",
                    "rm:id": "15541746",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2015-04-17T01:04:45Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-07T11:53:40Z",
                    "from_date": "2014",
                    "to_date": "9999",
                    "rm:institution_code": "1100000000",
                    "affiliation": {
                        "ja": "札幌医科大学",
                        "en": "Sapporo Medical University"
                    },
                    "section": {
                        "ja": "フロンティア医学研究所分子医学部門"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_experience/15541745",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_experience",
                    "rm:id": "15541745",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2015-04-17T01:02:53Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-07T11:53:50Z",
                    "from_date": "2011",
                    "to_date": "2013",
                    "rm:institution_code": "1100000000",
                    "affiliation": {
                        "ja": "札幌医科大学",
                        "en": "Sapporo Medical University"
                    },
                    "section": {
                        "ja": "フロンティア医学研究所遺伝子工学部門"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_experience/4256877",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_experience",
                    "rm:id": "4256877",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-07T11:53:53Z",
                    "from_date": "1999",
                    "to_date": "2010",
                    "rm:institution_code": "1100000000",
                    "affiliation": {
                        "ja": "札幌医科大学",
                        "en": "Sapporo Medical University"
                    },
                    "section": {
                        "ja": "教育研究機器センター分子医学研究部門"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0019681/published_papers",
            "@type": "published_papers",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 25,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/47867167",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "47867167",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-09-20T04:05:42Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-09-20T04:05:42Z",
                    "paper_title": {
                        "en": "A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Masashi Idogawa"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Hiroaki Uchida"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "Few effective treatments are available for small cell lung cancer (SCLC), indicating the need to explore new therapeutic options. Here, we focus on an antibody-drug conjugate (ADC) targeting the L1 cell adhesion molecule (L1CAM). Several publicly available databases reveal that (1) L1CAM is expressed at higher levels in SCLC cell lines and tissues than in those of lung adenocarcinoma and (2) the expression levels of L1CAM are slightly higher in SCLC tissues than in adjacent normal tissues. We conducted a series of in vitro experiments using an anti-L1CAM monoclonal antibody (termed HSL175, developed in-house) and the recombinant protein DT3C, which consists of diphtheria toxin lacking the receptor-binding domain but containing the C1, C2, and C3 domains of streptococcal protein G. Our HSL175-DT3C conjugates theoretically kill cells only when the conjugates are internalized by the target (L1CAM-positive) cells through antigen-antibody interaction. The conjugates (an ADC analog) were effective against two SCLC-N (NEUROD1 dominant) cell lines, Lu-135 and STC-1, resulting in decreased viability. In addition, L1CAM silencing rendered the two cell lines resistant to HSL175-DT3C conjugates. These findings suggest that an ADC consisting of a humanized monoclonal antibody based on HSL175 and a potent anticancer drug would be effective against SCLC-N cells."
                    },
                    "publication_date": "2024-08-11",
                    "publication_name": {
                        "en": "International journal of molecular sciences"
                    },
                    "volume": "25",
                    "number": "16",
                    "languages": [
                        "eng"
                    ],
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.3390/ijms25168748"
                        ],
                        "pm_id": [
                            "39201435"
                        ],
                        "pmc_id": [
                            "PMC11354272"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.3390/ijms25168748",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/39201435",
                            "is_downloadable": false
                        },
                        {
                            "label": "pmc",
                            "@id": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11354272",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/47146024",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "47146024",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2024-07-18T04:35:37Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2024-07-18T04:36:43Z",
                    "paper_title": {
                        "en": "Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Sakuma"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Masashi Idogawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Few efficacious treatment options are available for patients with small cell lung carcinoma (SCLC), indicating the need to develop novel therapeutic approaches. In this study, we explored kinesin family member 11 (KIF11), a potential therapeutic target in SCLC. An analysis of publicly available data suggested that KIF11 mRNA expression levels are significantly higher in SCLC tissues than in normal lung tissues. When KIF11 was targeted by RNA interference or a small-molecule inhibitor (SB743921) in two SCLC cell lines, Lu-135 and NCI-H69, cell cycle progression was arrested at the G2/M phase with complete growth suppression. Further work suggested that the two cell lines were more significantly affected when both KIF11 and BCL2L1, an anti-apoptotic BCL2 family member, were inhibited. This dual inhibition resulted in markedly decreased cell viability. These findings collectively indicate that SCLC cells are critically dependent on KIF11 activity for survival and/or proliferation, as well as that KIF11 inhibition could be a new strategy for SCLC treatment."
                    },
                    "publication_date": "2024-06-30",
                    "publication_name": {
                        "en": "International journal of molecular sciences"
                    },
                    "volume": "25",
                    "number": "13",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.3390/ijms25137230"
                        ],
                        "pm_id": [
                            "39000337"
                        ],
                        "pmc_id": [
                            "PMC11241341"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.3390/ijms25137230",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/39000337",
                            "is_downloadable": false
                        },
                        {
                            "label": "pmc",
                            "@id": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11241341",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/43303128",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "43303128",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2023-09-03T03:31:58Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2023-12-12T05:15:51Z",
                    "paper_title": {
                        "en": "Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Sakuma"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            }
                        ]
                    },
                    "description": {
                        "en": "EGFR-mutant lung adenocarcinoma (LUAD) mostly depends on EGFR for survival and consequently responds well to EGFR inhibitors. However, resistance to the drugs develops almost universally during treatment. We previously demonstrated that EGFR-mutant LUAD cell lines, HCC827 and H1975, have subpopulations of cells, which we termed HCC827 GR2 and H1975 WR7 cells, that can thrive independently of EGFR signaling. These EGFR-independent EGFR-mutant cancer cells are difficult to treat because they lack sensitivity to EGFR inhibitors. Therefore, the development of novel strategies to target EGFR-independent EGFR-mutant LUAD is particularly important. We found that high expression of kinesin family member 11 (KIF11) correlated with poor survival in patients with LUAD. We also observed that KIF11 silencing caused cell cycle arrest at G2/M in HCC827 GR2 and H1975 WR7 cells. Furthermore, dual silencing of KIF11 plus BCL2L1, an anti-apoptotic BCL2 family member, in these two EGFR-independent sublines resulted in marked apoptosis levels. Dual inhibition of KIF11 plus BCL2L1 also induced apoptosis in HCC827 and H1975 parental cells and a KRAS-mutant LUAD cell line, H441. These findings collectively suggest that dual inhibition of KIF11 plus BCL2L1 may be a new approach for the treatment of LUAD."
                    },
                    "publication_date": "2023-08-19",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "678",
                    "starting_page": "84",
                    "ending_page": "89",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2023.08.039"
                        ],
                        "pm_id": [
                            "37619315"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2023.08.039",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/37619315",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/42185839",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "42185839",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2023-05-02T03:31:23Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2023-10-20T06:18:09Z",
                    "paper_title": {
                        "en": "Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Masashi Idogawa"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Hiroaki Uchida"
                            },
                            {
                                "name": "Naoki Fujitani"
                            },
                            {
                                "name": "Motoko Takahashi"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "There are few effective therapies for small cell lung carcinoma (SCLC); thus, we need to develop novel and efficacious treatments. We hypothesized that an antibody-drug conjugate (ADC) could be a promising option for SCLC. Several publicly available databases were used to demonstrate the extent to which junctional adhesion molecule 3 (JAM3) mRNA was expressed in SCLC and lung adenocarcinoma cell lines and tissues. Three SCLC cell lines, Lu-135, SBC-5, and Lu-134 A, were selected and examined for JAM3 protein expression by flow cytometry. Finally, we examined the response of the three SCLC cell lines to a conjugate between an anti-JAM3 monoclonal antibody HSL156 (developed in-house) and the recombinant protein DT3C, which consists of diphtheria toxin lacking the receptor-binding domain but containing the C1, C2, and C3 domains of streptococcal protein G. In silico analyses revealed that JAM3 mRNA was expressed higher in SCLC cell lines and tissues than in those of lung adenocarcinoma. As expected, all the three SCLC cell lines examined were positive for JAM3 at the mRNA and protein levels. Consequently, control SCLC cells, but not JAM3-silenced ones, were highly sensitive to HSL156-DT3C conjugates, resulting in dose- and time-dependent decreased viability. Finally, silencing JAM3 alone suppressed the growth of all SCLC cell lines examined. Taken together, these findings suggest that an ADC targeting JAM3 could represent a new approach to treating SCLC patients."
                    },
                    "publication_date": "2023-05-15",
                    "publication_name": {
                        "en": "Experimental cell research"
                    },
                    "volume": "426",
                    "number": "2",
                    "starting_page": "113570",
                    "ending_page": "113570",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.yexcr.2023.113570"
                        ],
                        "pm_id": [
                            "36990421"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.yexcr.2023.113570",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/36990421",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/40492701",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "40492701",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-11-15T06:11:26Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-11-15T06:13:08Z",
                    "paper_title": {
                        "en": "Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Masashi Idogawa"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "published_paper_owner_roles": [
                        "lead"
                    ],
                    "description": {
                        "en": "Non-small cell lung carcinomas (NSCLCs), especially lung adenocarcinomas (LUADs), harbor several driver mutations against which highly effective tyrosine kinase inhibitors (TKIs) are available. Although TKIs are generally effective against certain NSCLCs, primary or acquired resistance almost always develops. Driver mutations include RET fusion (∼1-2% of NSCLC cases) and MET exon 14 skipping mutation (METΔex14; ∼3-4%). Surprisingly, the LUAD cell line LC-2/ad with CCDC6-RET fusion thrived independently of RET signaling, and Hs-746T cells harboring METΔex14 plus amplification survived MET silencing. However, these two cell lines were highly sensitive to dual silencing of the representative anti-apoptotic BCL2 family members BCL2L1 and MCL1, undergoing extensive apoptosis in monolayer or 3D on-top culture systems. Moreover, we found that most LUAD cell lines and tissues expressed high levels of BCL2L1 and MCL1 mRNA but extremely low levels of BCL2. Together, these findings suggest that inhibiting BCL2L1 plus MCL1 may represent a new approach to treating LUAD cells irrespective of their driver mutations."
                    },
                    "publication_date": "2022-11-19",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "630",
                    "starting_page": "24",
                    "ending_page": "29",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2022.09.039"
                        ],
                        "pm_id": [
                            "36126466"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2022.09.039",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/36126466",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36603269",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36603269",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-03-30T05:35:02Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-03-30T05:35:54Z",
                    "paper_title": {
                        "en": "Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Masashi Idogawa"
                            },
                            {
                                "name": "Hiroaki Uchida"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "Although MET tyrosine kinase inhibitors (TKIs) are generally effective against non-small cell lung carcinoma (NSCLC) with MET exon 14 skipping mutations (METΔex14), resistance to MET TKIs can occur, indicating the need to develop other therapeutic options. We found that Hs-746 T cells, which harbor METΔex14 plus amplification, were able to survive and grow in the absence of MET signaling, exhibiting primary resistance to MET TKIs. We also found a moderately positive correlation between MET and anthrax toxin receptor 2 (ANTXR2) mRNA expression in NSCLC cell lines using data from the Cancer Dependency Map database. As expected, Hs-746 T cells were positive for ANTXR2 expression. We used an antibody-drug conjugate (ADC) analog in the form of an anti-ANTXR2 monoclonal antibody, H8R23, conjugated to DT3C recombinant protein which consists of diphtheria toxin (DT) lacking the receptor-binding domain but containing the C1, C2, and C3 domains of streptococcal protein G (3C). H8R23-DT3C conjugates, which function in vitro like an ADC, induced Hs-746 T cells to undergo apoptosis, resulting in decreased viability. These findings collectively suggest that an ADC targeting ANTXR2 could be effective for the treatment of METΔex14-positive NSCLC."
                    },
                    "publication_date": "2022-04-15",
                    "publication_name": {
                        "en": "Experimental cell research"
                    },
                    "volume": "413",
                    "number": "2",
                    "starting_page": "113078",
                    "ending_page": "113078",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.yexcr.2022.113078"
                        ],
                        "pm_id": [
                            "35189107"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.yexcr.2022.113078",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/35189107",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198082",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198082",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:47Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:52:36Z",
                    "paper_title": {
                        "en": "MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Sakuma"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Takashi Kojima"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            }
                        ]
                    },
                    "description": {
                        "en": "MCL1 is an anti-apoptotic BCL2 family member that is often overexpressed in various malignant tumors. However, few reports have described the role of MCL1 in squamous cell carcinoma (SqCC) derived from airways including the lung. In this study, we examined whether MCL1 could be a novel druggable target for airway-derived SqCC, for which effective molecular targeted drugs are unavailable. We searched the Kaplan-Meier Plotter database and found that high MCL1 mRNA expression was significantly associated with shorter survival in patients with lower airway (lung) or upper airway (head and neck) derived SqCC. We also explored the Expression Atlas database and learned that authentic lung SqCC cell lines expressing both TP63 and KRT5 mRNA were extremely sparse among the publicly available \"lung SqCC cell lines\", with an exception being HARA cells. HARA cells were highly dependent on MCL1 for survival, and MCL1-depleted cells were not able to grow, and even declined in number, upon docetaxel (DTX) exposure in vitro and in vivo. Similar in vitro experimental findings, including those in a 3D culture model, were also obtained using Detroit 562 pharyngeal SqCC cells. These findings suggested that combined treatment with MCL1 silencing plus DTX appears highly effective against airway-derived SqCC."
                    },
                    "publication_date": "2021-09",
                    "publication_name": {
                        "en": "Experimental cell research"
                    },
                    "volume": "406",
                    "number": "2",
                    "starting_page": "112763",
                    "ending_page": "112763",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.yexcr.2021.112763"
                        ],
                        "pm_id": [
                            "34358524"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.yexcr.2021.112763",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/34358524",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198083",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198083",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:47Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:53:00Z",
                    "paper_title": {
                        "en": "Pericyte-myofibroblast transition in the human lung."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease that includes fibroblastic foci (FF). It has been increasingly appreciated that the origin of collagen-overproducing cells such as pathological myofibroblasts in FF is pericytes. However, neither pericytes derived from the lung nor FF in the IPF lung have not been fully characterized. Human lung pericytes (HuL-P) examined in this study expressed two representative pericyte markers; platelet-derived growth factor receptor β (PDGFRB) and chondroitin sulfate proteoglycan 4 (CSPG4), and were able to migrate and cover endothelial tubes in 3D conditions, indicating that they retain characteristics of pericytes. Moreover HuL-P cells transitioned to myofibroblast-like cells in the presence of transforming growth factor (TGF)-β signaling or to pericyte-like cells in the absence of TGF-β signaling (pericyte-myofibroblast transition). On the other hand, the FF detected in this study were invariably localized between peripheral lung epithelia and capillary endothelia, the basement membranes of which are physiologically fused. The localization is highly specific in that the only cells that exist between the gap are pericytes. As expected, FF were immunohistochemically positive for PDGFRB and CSPG4, suggesting that pericytes are activated to form FF. We also found that HuL-P cells were difficult to eradicate by dual silencing of Bcl-xL plus MCL1. It would be more sensible to suppress pericyte-myofibroblast transition than to kill activated myofibroblasts for the treatment of IPF."
                    },
                    "publication_date": "2020-07",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "528",
                    "number": "2",
                    "starting_page": "269",
                    "ending_page": "275",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2020.05.091"
                        ],
                        "pm_id": [
                            "32473754"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2020.05.091",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/32473754",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198084",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198084",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:47Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:54:30Z",
                    "paper_title": {
                        "en": "EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survival."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "published_paper_owner_roles": [
                        "lead"
                    ],
                    "description": {
                        "en": "Although most EGFR-mutant lung adenocarcinomas initially respond to EGFR inhibitors, disease progression almost inevitably occurs. We previously reported that two EGFR-mutant lung adenocarcinoma cell lines, HCC827 and H1975, contain subpopulations of cells that display an epithelial-to-mesenchymal phenotype and can thrive independently of EGFR signaling. In this study, we explored to what extent these two sublines, HCC827 GR2 and H1975 WR7, depended on the anti-apoptotic BCL2 family members, Bcl-xL and/or MCL1, for survival. Although HCC827 GR2 cells were hardly affected by Bcl-xL or MCL1 knockdown alone, dual inhibition of Bcl-xL and MCL1 caused the cells to undergo apoptosis, resulting in decreased viability. In H1975 WR7 cells, not only dual inhibition, but also MCL1 silencing alone, induced the cells to undergo apoptosis. Interestingly, the two sublines markedly declined in number when autophagy flux was suppressed, because they depend, in part, on active autophagy for survival. However, autophagy inhibition was inferior to dual inhibition of Bcl-xL plus MCL1 for GR2 cells, or MCL1 inhibition alone, for decreasing the viability of WR7 cells. Collectively, these findings suggest that inhibiting Bcl-xL plus MCL1, or MCL1 alone, may represent a new approach to treat EGFR-independent EGFR-mutant cancer cells."
                    },
                    "publication_date": "2020-05",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "526",
                    "number": "2",
                    "starting_page": "417",
                    "ending_page": "423",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2020.03.116"
                        ],
                        "pm_id": [
                            "32223928"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2020.03.116",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/32223928",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198085",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198085",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:47Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:54:52Z",
                    "paper_title": {
                        "en": "MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Masahiro Miyajima"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "OBJECTIVES: MCL1 is an anti-apoptotic BCL2 family member that is highly expressed in various malignant tumors. However, little is known about the role of MCL1 in KRAS-mutant lung adenocarcinomas. In this study, we aimed to clarify whether MCL1 could be a therapeutic target in KRAS-mutant lung adenocarcinomas for which no effective molecular targeted drugs are available. MATERIALS AND METHODS: We examined to what extent MCL1 knockdown either alone or in combination with MEK inhibitor trametinib suppressed growth or induced apoptosis in the KRAS-mutant lung adenocarcinoma cell line H441 and EGFR-mutant lung adenocarcinoma cell line H1975. Furthermore, we investigated the therapeutic effects of dual inhibition of MCL1 and Bcl-xL, another anti-apoptotic BCL2 family member, in these two cell lines. RESULTS: MCL1 knockdown alone did not induce apoptosis in H441 or H1975 cells. However, MCL1-depleted H441 and H1975 cells underwent apoptosis and decreased in number in the presence of trametinib. We also confirmed that combined therapy by MCL1 knockdown and trametinib almost completely suppressed the growth of H441 cells in vivo. Moreover, dual knockdown of MCL1 and Bcl-xL induced extensive apoptosis in H441 and H1975 cells. CONCLUSION: These findings suggest that combined treatments of MCL1 knockdown and trametinib or dual inhibition of MCL1 and Bcl-xL would be effective therapies for lung adenocarcinomas including the KRAS-mutant subtype."
                    },
                    "publication_date": "2019-07",
                    "publication_name": {
                        "en": "Lung cancer (Amsterdam, Netherlands)"
                    },
                    "volume": "133",
                    "starting_page": "88",
                    "ending_page": "95",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.lungcan.2019.05.014"
                        ],
                        "pm_id": [
                            "31200834"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.lungcan.2019.05.014",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/31200834",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198086",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198086",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:47Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:55:18Z",
                    "paper_title": {
                        "en": "Characterization of distal airway stem-like cells expressing N-terminally truncated p63 and thyroid transcription factor-1 in the human lung."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Atsushi Saito"
                            },
                            {
                                "name": "Hirofumi Chiba"
                            },
                            {
                                "name": "Takashi Kojima"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "Distal airway stem cells (DASCs) in the mouse lung can differentiate into bronchioles and alveoli. However, it remains unclear whether the same stem cells exist in the human lung. Here, we found that human lung epithelial (HuL) cells, derived from normal, peripheral lung tissue, in monolayer, mostly express both the N-terminally truncated isoform of p63 (∆Np63), a marker for airway basal cells, and thyroid transcription factor-1 (TTF-1), a marker for alveolar epithelial cells, even though these two molecules are usually expressed in a mutually exclusive way. Three-dimensionally cultured HuL cells differentiated to form bronchiole-like and alveolus-like organoids. We also uncovered a few bronchiolar epithelial cells expressing both ∆Np63 and TTF-1 in the human lung, suggesting that these cells are the cells of origin for HuL cells. Taken together, ΔNp63+ TTF-1+ peripheral airway epithelial cells are possibly the human counterpart of mouse DASCs and may offer potential for future regenerative medicine."
                    },
                    "publication_date": "2018-11",
                    "publication_name": {
                        "en": "Experimental cell research"
                    },
                    "volume": "372",
                    "number": "2",
                    "starting_page": "141",
                    "ending_page": "149",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.yexcr.2018.09.020"
                        ],
                        "pm_id": [
                            "30268759"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.yexcr.2018.09.020",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/30268759",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198088",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198088",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:48Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:55:45Z",
                    "paper_title": {
                        "en": "Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Gen Yamada"
                            },
                            {
                                "name": "Tadashi Hasegawa"
                            },
                            {
                                "name": "Yohei Miyagi"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "Survivin plays a key role in regulating the cell cycle and apoptosis, and is highly expressed in the majority of malignant tumors. However, little is known about the roles of survivin in KRAS-mutant lung adenocarcinomas. In the present study, we examined 28 KRAS-mutant lung adenocarcinoma tissues and two KRAS-mutant lung adenocarcinoma cell lines, H358 and H441, in order to elucidate the potential of survivin as a therapeutic target. We found that 19 (68%) of the 28 KRAS-mutant lung adenocarcinomas were differentiated tumors expressing thyroid transcription factor‑1 (TTF‑1) and E-cadherin. Patients with tumors immunohistochemically positive for survivin (n=18) had poorer outcomes than those with survivin-negative tumors (n=10). In the H358 and H441 cells, which expressed TTF‑1 and E-cadherin, survivin knockdown alone induced senescence, not apoptosis. However, in monolayer culture, the H358 cells and H441 cells in which survivin was silenced, underwent significant apoptosis following combined treatment with ABT-263, a Bcl‑2 inhibitor, and trametinib, a MEK inhibitor. Importantly, the triple combination of survivin knockdown with ABT-263 and trametinib treatment, clearly induced cell death in a three-dimensional cell culture model and in an in vivo tumor xenograft model. We also observed that the growth of the H358 and H441 cells was slightly, yet significantly suppressed in vitro when TTF‑1 was silenced. These findings collectively suggest that the triple combination of survivin knockdown with ABT-263 and trametinib treatment, may be a potential strategy for the treatment of KRAS-mutant lung adenocarcinoma. Furthermore, our findings indicate that the well‑differentiated type of KRAS-mutant lung tumors depends, at least in part, on TTF‑1 for growth."
                    },
                    "publication_date": "2018-07",
                    "publication_name": {
                        "en": "International journal of oncology"
                    },
                    "volume": "53",
                    "number": "1",
                    "starting_page": "33",
                    "ending_page": "46",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.3892/ijo.2018.4365"
                        ],
                        "pm_id": [
                            "29658609"
                        ],
                        "pmc_id": [
                            "PMC5958877"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.3892/ijo.2018.4365",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/29658609",
                            "is_downloadable": false
                        },
                        {
                            "label": "pmc",
                            "@id": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958877",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198087",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198087",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:48Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:56:11Z",
                    "paper_title": {
                        "en": "Trametinib downregulates survivin expression in RB1-positive KRAS-mutant lung adenocarcinoma cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "High expression levels of survivin in KRAS-mutant lung adenocarcinomas are linked with unfavorable patient outcomes, suggesting that survivin is a promising target for tumor treatment. We found that trametinib, a MEK inhibitor, downregulates survivin expression in the RB1-positive KRAS-mutant lung adenocarcinoma cell lines H358 and H441. In these cell lines, trametinib treatment induced p21 expression and dephosphorylated RB1, leading to sustained suppression of survivin. Knockdown of p21 or RB1 restored survivin expression in trametinib-treated cells, at least partially, which supports the contribution of these molecules to trametinib-mediated survivin suppression. In RB1-negative KRAS-mutant lung adenocarcinoma H2009 cells, survivin downregulation by trametinib was only slight and transient, and trametinib-resistant (TR) cells developed within 1 month of treatment. H2009 TR cells depended much more on survivin for survival than its parental cells, as evidenced by apoptosis induction when survivin was depleted. These findings collectively suggest that trametinib is effective for the treatment of RB1-positive KRAS-mutant lung adenocarcinomas through sustained survivin suppression, but not for RB1-negative lung adenocarcinomas. Thus, the RB1 status could be a biomarker for trametinib application in KRAS-mutant lung adenocarcinomas."
                    },
                    "publication_date": "2018-06",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "501",
                    "number": "1",
                    "starting_page": "253",
                    "ending_page": "258",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2018.04.230"
                        ],
                        "pm_id": [
                            "29727601"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2018.04.230",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/29727601",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198090",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198090",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:48Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:56:38Z",
                    "paper_title": {
                        "en": "Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Makoto Tada"
                            },
                            {
                                "name": "Yukari Nishii"
                            },
                            {
                                "name": "Tadashi Hasegawa"
                            },
                            {
                                "name": "Hiroaki Uchida"
                            },
                            {
                                "name": "Gen Yamada"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "EGFR-mutant lung adenocarcinomas contain a subpopulation of cells that have undergone epithelial-to-mesenchymal transition and can grow independently of EGFR. To kill these cancer cells, we need a novel therapeutic approach other than EGFR inhibitors. If a molecule is specifically expressed on the cell surface of such EGFR-independent EGFR-mutant cancer cells, it can be a therapeutic target. We found that a mesenchymal EGFR-independent subline derived from HCC827 cells, an EGFR-mutant lung adenocarcinoma cell line, expressed angiotensin-converting enzyme 2 (ACE2) to a greater extent than its parental cells. ACE2 was also expressed at least partially in most of the primary EGFR-mutant lung adenocarcinomas examined, and the ACE2 expression level in the cancer cells was much higher than that in normal lung epithelial cells. In addition, we developed an anti-ACE2 mouse monoclonal antibody (mAb), termed H8R64, that was internalized by ACE2-expressing cells. If an antibody-drug conjugate consisting of a humanized mAb based on H8R64 and a potent anticancer drug were produced, it could be effective for the treatment of EGFR-mutant lung adenocarcinomas."
                    },
                    "publication_date": "2017-06",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "487",
                    "number": "3",
                    "starting_page": "613",
                    "ending_page": "618",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2017.04.102"
                        ],
                        "pm_id": [
                            "28433633"
                        ],
                        "pmc_id": [
                            "PMC7092918"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2017.04.102",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/28433633",
                            "is_downloadable": false
                        },
                        {
                            "label": "pmc",
                            "@id": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092918",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198091",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198091",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:48Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:57:06Z",
                    "paper_title": {
                        "en": "Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Yusuke Tanaka"
                            },
                            {
                                "name": "Toshiyuki Sumi"
                            },
                            {
                                "name": "Masahiro Miyajima"
                            },
                            {
                                "name": "Taijiro Mishina"
                            },
                            {
                                "name": "Gen Yamada"
                            },
                            {
                                "name": "Mitsuo Otsuka"
                            },
                            {
                                "name": "Tadashi Hasegawa"
                            },
                            {
                                "name": "Takashi Kojima"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            },
                            {
                                "name": "Yuji Sakuma"
                            }
                        ]
                    },
                    "description": {
                        "en": "Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease of unknown cause. IPF has a distinct histopathological pattern of usual interstitial pneumonia in which fibroblastic foci (FF) represent the leading edge of fibrotic destruction of the lung. Currently there are three major hypotheses for how FF are generated: (1) from resident fibroblasts, (2) from bone marrow-derived progenitors of fibroblasts, and (3) from alveolar epithelial cells that have undergone epithelial-mesenchymal transition (EMT). We found that FF dissociated capillary vessels from the alveolar epithelia, the basement membranes of which are fused in normal physiological conditions, and pushed the capillaries and elastic fibers down ~100 μm below the alveolar epithelia. Furthermore, the alveolar epithelial cells covering the FF exhibited a partial EMT phenotype. In addition, normal human alveolar epithelial cells in vitro underwent dynamic EMT in response to transforming growth factor-β signaling within 72 h. Because it seems that resident fibroblasts or bone marrow-derived cells cannot easily infiltrate and form FF between the alveolar epithelia and capillaries in tight contact with each other, FF are more likely to be derived from the epithelial-to-mesenchymal transitioned alveolar epithelia located over them. Moreover, histology and immunohistochemistry suggested that the FF formed in the lung parenchyma disrupt blood flow to the alveolar septa, thus destroying them. Consequently, collapse of the alveolar septa is likely to be the first step toward honeycombing in the lung during late stage IPF. On the basis of these findings, inhibition of transforming growth factor-β signaling, which can suppress EMT of the alveolar epithelial cells in vitro, is a potential strategy for treating IPF."
                    },
                    "publication_date": "2017-03",
                    "publication_name": {
                        "en": "Laboratory investigation; a journal of technical methods and pathology"
                    },
                    "volume": "97",
                    "number": "3",
                    "starting_page": "232",
                    "ending_page": "242",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1038/labinvest.2016.135"
                        ],
                        "pm_id": [
                            "27941755"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/labinvest.2016.135",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/27941755",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198092",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198092",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:48Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:57:25Z",
                    "paper_title": {
                        "en": "Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial-mesenchymal transition phenotype."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Sakuma"
                            },
                            {
                                "name": "Hirotaka Nishikiori"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Gen Yamada"
                            },
                            {
                                "name": "Atsushi Watanabe"
                            },
                            {
                                "name": "Tadashi Hasegawa"
                            },
                            {
                                "name": "Takashi Kojima"
                            },
                            {
                                "name": "Toshiro Niki"
                            },
                            {
                                "name": "Hiroki Takahashi"
                            }
                        ]
                    },
                    "description": {
                        "en": "The secondary epidermal growth factor receptor (EGFR) T790M mutation is the most prominent mechanism that confers resistance to first- or second-generation EGFR tyrosine kinase inhibitors (TKIs) in lung cancer treatment. Although third-generation EGFR TKIs can suppress the kinase activity of T790M-positive EGFR, they still cannot eradicate EGFR-mutated cancer cells. We previously reported that a subpopulation of EGFR-mutant lung adenocarcinomas depends on enhanced autophagy, instead of EGFR, for survival, and in this study we explore another mechanism that contributes to TKI resistance. We demonstrate here that an EGFR-mutant lung adenocarcinoma cell line, H1975 (L858R+T790M), has a subset of cells that exhibits an epithelial-mesenchymal transition (EMT) phenotype and can thrive in the presence of third-generation EGFR TKIs. These cells depend on not only autophagy but also on the isomerase Pin1 for survival in vitro, unlike their parental cells. The Pin1 protein was expressed in an EGFR-mutant lung cancer tissue that has undergone partial EMT and acquired resistance to EGFR TKIs, but not its primary tumor. These findings suggest that inhibition of Pin1 activity can be a novel strategy in lung cancer treatment."
                    },
                    "publication_date": "2016-04",
                    "publication_name": {
                        "en": "Laboratory investigation; a journal of technical methods and pathology"
                    },
                    "volume": "96",
                    "number": "4",
                    "starting_page": "391",
                    "ending_page": "8",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1038/labinvest.2015.155"
                        ],
                        "pm_id": [
                            "26752745"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/labinvest.2015.155",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/26752745",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198093",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198093",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:48Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T02:02:28Z",
                    "paper_title": {
                        "en": "Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Yukari Nishii"
                            },
                            {
                                "name": "Kiminori Nakamura"
                            },
                            {
                                "name": "Haruka Aoki"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Hiroaki Uchida"
                            },
                            {
                                "name": "Yuji Sakuma"
                            },
                            {
                                "name": "Hirofumi Hamada"
                            }
                        ]
                    },
                    "description": {
                        "en": "Antibody-drug conjugates (ADCs), drugs developed by conjugation of an anticancer agent to a monoclonal antibody (mAb), have lately attracted attention in cancer therapy because ADCs can directly bind cancer cells and kill them. Although mAbs for ADCs must be internalized by the target cells, few methods are available for screening mAbs for their ability to be internalized by cells. We have developed a recombinant protein, termed DT3C, which consists of diphtheria toxin (DT) lacking the receptor-binding domain but containing the C1, C2, and C3 domains of Streptococcus protein G (3C). When a mAb-DT3C conjugate, which functions in vitro like an ADC, reduces the viability of cancer cells, the mAb being tested must have been internalized by the target cells. DT3C can thus be a tool to identify efficiently and easily mAbs that can be internalized by cells, thereby enhancing the development of promising ADCs."
                    },
                    "publication_date": "2014-11",
                    "publication_name": {
                        "en": "Biochemical and biophysical research communications"
                    },
                    "volume": "454",
                    "number": "4",
                    "starting_page": "600",
                    "ending_page": "3",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.bbrc.2014.10.133"
                        ],
                        "pm_id": [
                            "25450699"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.bbrc.2014.10.133",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/25450699",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198094",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198094",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:49Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:58:55Z",
                    "paper_title": {
                        "en": "Epigenetic modulation enhances the therapeutic effect of anti-IL-13R(alpha)2 antibody in human mesothelioma xenografts."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Makoto Takenouchi"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Naoya Sakuragi"
                            },
                            {
                                "name": "Hideo Yagita"
                            },
                            {
                                "name": "Hirofumi Hamada"
                            },
                            {
                                "name": "Kazunori Kato"
                            }
                        ]
                    },
                    "description": {
                        "en": "PURPOSE: The interleukin-13 receptor α2 (IL-13Rα2) is expressed by a variety of human malignant cells. Here, we have examined the constitutive surface expression and the epigenetic regulation of IL-13Rα2 by human mesothelioma. We have also investigated the therapeutic effect of the DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-dC) and anti-IL-13Rα2 monoclonal antibody on mesothelioma xenografts. EXPERIMENTAL DESIGN: Cell surface expression of IL-13Rα2 by various lung carcinomas was analyzed using flow cytometry. Therapeutic effects of anti-IL-13Rα2 and 5-aza-dC were investigated using antibody-dependent cellular cytotoxicity and proliferation assays and by monitoring the survival of mesothelioma-bearing mice. RESULTS: We found that human malignant mesotheliomas expressed surface IL-13Rα2 on their surface and that it was upregulated by treatment with 5-aza-dC. This augmented expression of IL-13Rα2 resulted in growth inhibition of the mesothelioma cells when cocultured with anti-IL-13Rα2 and effector cells, such as splenocytes and peritoneal exudate cells. The growth inhibition of mesothelioma cells was mediated by IFN-γ that was only detected in the supernatant when effector cells were exposed to 5-aza-dC-treated tumors in the presence of anti-IL-13Rα2. Compared with the control or either regimen alone, in vivo administration of anti-IL-13Rα2 in combination with 5-aza-dC significantly prolonged the survival of mice with mesothelioma xenografts. CONCLUSIONS: These observations indicate a promising role for IL-13Rα2 as a target for antibody treatment in malignant mesothelioma, and, in combination with epigenetic regulation by a DNA methylation inhibitor, suggest the potential for a novel strategy to enhance therapeutic potency."
                    },
                    "publication_date": "2011-05",
                    "publication_name": {
                        "en": "Clinical cancer research : an official journal of the American Association for Cancer Research"
                    },
                    "volume": "17",
                    "number": "9",
                    "starting_page": "2819",
                    "ending_page": "29",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1158/1078-0432.CCR-10-2986"
                        ],
                        "pm_id": [
                            "21357681"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1158/1078-0432.CCR-10-2986",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/21357681",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/36198095",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "36198095",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:39:49Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T01:59:20Z",
                    "paper_title": {
                        "en": "Selective gene transfer into neurons via Na,K-ATPase beta1. Targeting gene transfer with monoclonal antibody and adenovirus vector."
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Keiji Ishii"
                            },
                            {
                                "name": "Kiminori Nakamura"
                            },
                            {
                                "name": "Satoshi Kawaguchi"
                            },
                            {
                                "name": "Rong Li"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Naoya Sakuragi"
                            },
                            {
                                "name": "Takuro Wada"
                            },
                            {
                                "name": "Kazunori Kato"
                            },
                            {
                                "name": "Toshihiko Yamashita"
                            },
                            {
                                "name": "Hirofumi Hamada"
                            }
                        ]
                    },
                    "description": {
                        "en": "BACKGROUND: Neuron-selective gene transfer is an attractive therapeutic strategy for neurological disorders. However, optimal targets and gene delivery systems remain to be determined. METHODS: Following immunization of mice with PC12 cells, hybridomas were screened by beta-Gal reporter gene assay using FZ33 fiber-modified adenovirus vectors. Subsequently, the efficacy and specificity of monoclonal antibody (mAb)-mediated gene transfer via FZ33 and FdZ adenovirus vectors were evaluated by flow cytometry, chemiluminescent beta-Gal reporter gene assay, and immunocytochemistry. Finally, the antigen recognized by the mAb was identified by mass spectrometry and transfection analysis. RESULTS: A hybridoma clone 6E3 producing monoclonal antibody, mAb6E3, was screened. Flow cytometry, chemiluminescent beta-Gal reporter gene assay, and immunocytochemistry with mAb6E3 and the fiber mutant adenovirus demonstrated efficient gene transfer into the PC12 cells. Treatment of neuron-glia cocultures with mAb6E3 and FdZ adenovirus resulted in neuron-selective gene transfer. Immunohistochemical images of rat spinal cord tissue showed that mAb6E3 reacts specifically with neurons. Finally, Na,K-ATPase beta1 was identified as the antigen of mAb6E3. CONCLUSIONS: Hybridoma screening using FZ33 fiber-modified adenovirus vectors serves as an efficient approach to detect antigens in mAb-targeted gene transfer. Neuronal tropism in the central nervous system through mAb6E3 represents an important initial step towards neuron-selective gene transfer in the treatment of local neurological disorders, such as spinal cord injury."
                    },
                    "publication_date": "2008-06",
                    "publication_name": {
                        "en": "The journal of gene medicine"
                    },
                    "volume": "10",
                    "number": "6",
                    "starting_page": "597",
                    "ending_page": "609",
                    "languages": [
                        "eng"
                    ],
                    "referee": true,
                    "published_paper_type": "scientific_journal",
                    "is_international_journal": true,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1002/jgm.1164"
                        ],
                        "pm_id": [
                            "18383483"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1002/jgm.1164",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/18383483",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/published_papers/48529754",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/read0019681/published_papers",
                    "rm:id": "48529754",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-11-25T02:20:36Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-11-25T02:20:36Z",
                    "paper_title": {
                        "ja": "CEAを標的としたファイバー改変型アデノウイルスベクターによる癌治療",
                        "en": "CEA-targeted Cancer Therapy Via Fiber Modified Adenovirus Vectors"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "田中 俊裕"
                            },
                            {
                                "name": "黒木 求"
                            },
                            {
                                "name": "黒木 政秀"
                            },
                            {
                                "name": "加藤 和則"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ],
                        "en": [
                            {
                                "name": "Toshihiro Tanaka"
                            },
                            {
                                "name": "Motomu Kuroki"
                            },
                            {
                                "name": "Masahide Kuroki"
                            },
                            {
                                "name": "Kazunori Kato"
                            },
                            {
                                "name": "Hirofumi Hamada"
                            }
                        ]
                    },
                    "publication_date": "2007-04",
                    "publication_name": {
                        "ja": "日本分子腫瘍マーカー研究会誌",
                        "en": "Japan Journal of Molecular Tumor Marker Research"
                    },
                    "volume": "22",
                    "starting_page": "57",
                    "ending_page": "58",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "published_paper_type": "international_conference_proceedings",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.11241/jsmtmr.22.57"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.11241/jsmtmr.22.57",
                            "is_downloadable": false
                        }
                    ]
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0019681/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 32,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198292",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198292",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:20Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T02:35:06Z",
                    "paper_title": {
                        "ja": "ヒト末梢気道幹細胞の研究"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "田中 悠祐"
                            },
                            {
                                "name": "角 俊行"
                            },
                            {
                                "name": "多田 周"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "渡辺 敦"
                            },
                            {
                                "name": "高橋 弘毅"
                            },
                            {
                                "name": "佐久間 裕司"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一社)日本呼吸器学会"
                    },
                    "publication_date": "2018-03",
                    "publication_name": {
                        "ja": "日本呼吸器学会誌"
                    },
                    "volume": "7",
                    "number": "増刊",
                    "starting_page": "153",
                    "ending_page": "153",
                    "languages": [
                        "jpn"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "2186-5876"
                        ],
                        "e_issn": [
                            "2186-5884"
                        ],
                        "jamas_id": [
                            "2018322443"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "url",
                            "@id": "https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2018&ichushi_jid=J05953&link_issn=&doc_id=20180327280377&doc_link_id=%2Fci6respo%2F2018%2Fs007s1%2F118%2F0153-0153%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fci6respo%2F2018%2Fs007s1%2F118%2F0153-0153%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198291",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198291",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:20Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-12T02:35:50Z",
                    "paper_title": {
                        "ja": "Kras変異陽性肺腺癌におけるsurvivinを標的とした治療戦略"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "角 俊行"
                            },
                            {
                                "name": "田中 悠祐"
                            },
                            {
                                "name": "多田 周"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "山田 玄"
                            },
                            {
                                "name": "渡辺 敦"
                            },
                            {
                                "name": "高橋 弘毅"
                            },
                            {
                                "name": "佐久間 裕司"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一社)日本呼吸器学会"
                    },
                    "publication_date": "2018-03",
                    "publication_name": {
                        "ja": "日本呼吸器学会誌"
                    },
                    "volume": "7",
                    "number": "増刊",
                    "starting_page": "210",
                    "ending_page": "210",
                    "languages": [
                        "jpn"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "2186-5876"
                        ],
                        "e_issn": [
                            "2186-5884"
                        ],
                        "jamas_id": [
                            "2018322744"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "url",
                            "@id": "https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2018&ichushi_jid=J05953&link_issn=&doc_id=20180327280678&doc_link_id=%2Fci6respo%2F2018%2Ft007s1%2F015%2F0210-0210%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fci6respo%2F2018%2Ft007s1%2F015%2F0210-0210%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198236",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198236",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:01Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-11-15T06:17:48Z",
                    "paper_title": {
                        "ja": "KRAS変異陽性肺腺癌におけるMCL1は治療標的分子となりえるか"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "多田周"
                            },
                            {
                                "name": "角俊行"
                            },
                            {
                                "name": "田中悠祐"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "高橋有毅"
                            },
                            {
                                "name": "鶴田航大"
                            },
                            {
                                "name": "槙龍之輔"
                            },
                            {
                                "name": "三品泰二郎"
                            },
                            {
                                "name": "宮島正博"
                            },
                            {
                                "name": "渡辺毅"
                            },
                            {
                                "name": "佐久間裕司"
                            }
                        ]
                    },
                    "publication_date": "2018",
                    "publication_name": {
                        "ja": "日本肺癌学会総会号"
                    },
                    "volume": "59th",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0386-9628"
                        ],
                        "j_global_id": [
                            "201802232544313221"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802232544313221",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198234",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198234",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:01Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-11-15T06:18:34Z",
                    "paper_title": {
                        "ja": "KRAS変異陽性肺腺癌におけるMCL1の治療標的分子としての基礎的検討"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "多田周"
                            },
                            {
                                "name": "角俊行"
                            },
                            {
                                "name": "田中悠祐"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "高橋有毅"
                            },
                            {
                                "name": "鶴田航大"
                            },
                            {
                                "name": "槙龍之輔"
                            },
                            {
                                "name": "三品泰二郎"
                            },
                            {
                                "name": "宮島正博"
                            },
                            {
                                "name": "渡辺敦"
                            },
                            {
                                "name": "佐久間裕司"
                            }
                        ]
                    },
                    "publication_date": "2018",
                    "publication_name": {
                        "ja": "日本呼吸器外科学会総会(Web)"
                    },
                    "volume": "35th",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "j_global_id": [
                            "201802282047594511"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802282047594511",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198293",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198293",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:21Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:29:37Z",
                    "paper_title": {
                        "ja": "KRAS変異陽性肺腺癌におけるMEK阻害薬trametinibとsurvivinの関連について"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "角 俊行"
                            },
                            {
                                "name": "田中 悠祐"
                            },
                            {
                                "name": "多田 周"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "佐久間 裕司"
                            },
                            {
                                "name": "山田 玄"
                            },
                            {
                                "name": "高橋 弘毅"
                            },
                            {
                                "name": "渡辺 敦"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(NPO)日本肺癌学会"
                    },
                    "publication_date": "2017-12",
                    "publication_name": {
                        "ja": "肺癌"
                    },
                    "volume": "57",
                    "number": "7",
                    "starting_page": "918",
                    "ending_page": "918",
                    "languages": [
                        "jpn"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0386-9628"
                        ],
                        "e_issn": [
                            "1348-9992"
                        ],
                        "jamas_id": [
                            "2018135904"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198242",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198242",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:02Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:40:44Z",
                    "paper_title": {
                        "ja": "末梢肺上皮幹細胞の基礎的研究"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "田中悠祐"
                            },
                            {
                                "name": "角俊行"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "渡辺敦"
                            },
                            {
                                "name": "高橋弘毅"
                            },
                            {
                                "name": "佐久間裕司"
                            }
                        ]
                    },
                    "publication_date": "2017",
                    "publication_name": {
                        "ja": "日本肺サーファクタント・界面医学会学術研究会プログラム・抄録集"
                    },
                    "volume": "53rd",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "j_global_id": [
                            "201802271480475878"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802271480475878",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198238",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198238",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:02Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:28:00Z",
                    "paper_title": {
                        "ja": "Kras変異陽性肺腺癌におけるsurvivinの治療標的分子としての基礎的検討"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "角俊行"
                            },
                            {
                                "name": "田中悠祐"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "山田玄"
                            },
                            {
                                "name": "渡辺敦"
                            },
                            {
                                "name": "高橋弘毅"
                            },
                            {
                                "name": "佐久間裕司"
                            }
                        ]
                    },
                    "publication_date": "2017",
                    "publication_name": {
                        "ja": "日本肺癌学会総会号"
                    },
                    "volume": "58th",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0386-9628"
                        ],
                        "j_global_id": [
                            "201702260487048821"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201702260487048821",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198295",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198295",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:21Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:28:20Z",
                    "paper_title": {
                        "en": "高性能モノクローナル抗体リソースの標的化改変ヘルペスウイルスベクタープラットフォームへの適用(Application of in-house monoclonal antibody resources to a fully retargeted oncolytic herpes simplex virus platform)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "大久保 優"
                            },
                            {
                                "name": "鈴木 拓真"
                            },
                            {
                                "name": "柴田 智子"
                            },
                            {
                                "name": "駒井 麻央"
                            },
                            {
                                "name": "福原 武志"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "宮川 世志幸"
                            },
                            {
                                "name": "Cohen Justus B."
                            },
                            {
                                "name": "Glorioso Joseph C."
                            },
                            {
                                "name": "濱田 洋文"
                            },
                            {
                                "name": "内田 宏昭"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2013-10",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "72回",
                    "starting_page": "208",
                    "ending_page": "208",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2015191662"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198294",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198294",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:21Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2023-10-20T06:20:03Z",
                    "paper_title": {
                        "en": "白血病/リンパ腫に対するスーパー標的抗体を用いたイムノトキシンの開発(Generation of immunotoxins with super-targeting mAb in the leukemia/lymphoma)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "西井 ゆかり"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "内田 宏昭"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2013-10",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "72回",
                    "starting_page": "353",
                    "ending_page": "353",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2015192333"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198243",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198243",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:03Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:28:27Z",
                    "paper_title": {
                        "ja": "単純ヘルペスウイルス標的化プラットフォームへのがん標的化抗体リソースの適用"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "大久保優"
                            },
                            {
                                "name": "鈴木拓真"
                            },
                            {
                                "name": "柴田智子"
                            },
                            {
                                "name": "駒井麻央"
                            },
                            {
                                "name": "福原武志"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "宮川世志幸"
                            },
                            {
                                "name": "COHEN Justus B"
                            },
                            {
                                "name": "GLORIOSO Joseph C"
                            },
                            {
                                "name": "濱田洋文"
                            },
                            {
                                "name": "内田宏昭"
                            }
                        ]
                    },
                    "publication_date": "2013",
                    "publication_name": {
                        "ja": "日本癌治療学会学術集会(CD-ROM)"
                    },
                    "volume": "51st",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "j_global_id": [
                            "201302285109845646"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201302285109845646",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198240",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198240",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:02Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:28:33Z",
                    "paper_title": {
                        "ja": "エンベロープ糖タンパクgDにがん標的化単鎖抗体を挿入した単純ヘルペスウイルスを用いた腫瘍溶解ウイルス療法の開発"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "鈴木拓真"
                            },
                            {
                                "name": "柴田智子"
                            },
                            {
                                "name": "大久保優"
                            },
                            {
                                "name": "福原武志"
                            },
                            {
                                "name": "宮川世志幸"
                            },
                            {
                                "name": "COHEN Justus"
                            },
                            {
                                "name": "GLORIOSO Joseph"
                            },
                            {
                                "name": "中野賢二"
                            },
                            {
                                "name": "熊谷泉"
                            },
                            {
                                "name": "黒木政秀"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "濱田洋文"
                            },
                            {
                                "name": "内田宏昭"
                            }
                        ]
                    },
                    "publication_date": "2013",
                    "publication_name": {
                        "ja": "日本ウイルス学会学術集会プログラム・抄録集"
                    },
                    "volume": "61st",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "j_global_id": [
                            "201302255813713791"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201302255813713791",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198239",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198239",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T06:55:02Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:28:40Z",
                    "paper_title": {
                        "ja": "単純ヘルペスウイルスの標的化改変プラットフォームへのがん標的化抗体インハウスリソースの適用"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "柴田智子"
                            },
                            {
                                "name": "鈴木拓真"
                            },
                            {
                                "name": "大久保優"
                            },
                            {
                                "name": "駒井麻央"
                            },
                            {
                                "name": "福原武志"
                            },
                            {
                                "name": "山口美樹"
                            },
                            {
                                "name": "平井幸恵"
                            },
                            {
                                "name": "宮川世志幸"
                            },
                            {
                                "name": "COHEN Justus"
                            },
                            {
                                "name": "GLORIOSO Joseph"
                            },
                            {
                                "name": "濱田洋文"
                            },
                            {
                                "name": "内田宏昭"
                            }
                        ]
                    },
                    "publication_date": "2013",
                    "publication_name": {
                        "ja": "日本ウイルス学会学術集会プログラム・抄録集"
                    },
                    "volume": "61st",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "j_global_id": [
                            "201302268322777652"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "j_global",
                            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201302268322777652",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198298",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198298",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:21Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:07:21Z",
                    "paper_title": {
                        "en": "メラノーマ標的化新規モノクローナル抗体の網羅的解析(Systematic screening of novel monoclonal antibodies targeting human melanoma cells)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2012-08",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "71回",
                    "starting_page": "148",
                    "ending_page": "148",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2013288572"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198297",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198297",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:21Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2023-10-20T06:20:16Z",
                    "paper_title": {
                        "en": "スーパー標的抗体を用いたimunotoxinの開発 AML(急性骨髄性白血病)に対する抗CD71抗体を用いた抗腫瘍活性(Generation of immunotoxins with super-targeting mAb: superior antitumor activities with anti-CD71 mAb against AML)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "西井 ゆかり"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2012-08",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "71回",
                    "starting_page": "338",
                    "ending_page": "338",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2013289487"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198302",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198302",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:22Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:07:22Z",
                    "paper_title": {
                        "en": "メラノーマに対する新規標的化抗体の樹立と機能解析(Establishment and evaluation of novel monoclonal antibodies targeting malignant melanoma)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2011-09",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "70回",
                    "starting_page": "501",
                    "ending_page": "501",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2012230361"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198301",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198301",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:22Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2023-10-20T06:22:59Z",
                    "paper_title": {
                        "en": "スーパー標的抗体を用いたimunotoxinの開発 非小細胞肺癌に対する抗CD59抗体を用いた抗腫瘍活性(Generation of immunotoxins with super-targeting mAb: superior antitumor activities with anti-CD59 mAb against NSCLC)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "西井 ゆかり"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2011-09",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "70回",
                    "starting_page": "501",
                    "ending_page": "501",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2012230362"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/28976719",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "28976719",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2020-07-12T10:45:42Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T06:58:52Z",
                    "paper_title": {
                        "en": "CD146-TARGETED SELECTIVE GENE TRANSFER INTO MELANOMA"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Naoya Sakuragi"
                            },
                            {
                                "name": "Miki Yamaguchi"
                            },
                            {
                                "name": "Kiminori Nakamura"
                            },
                            {
                                "name": "Kazunori Kato"
                            },
                            {
                                "name": "Hirofumi Hamada"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "JOHN WILEY & SONS LTD"
                    },
                    "publication_date": "2010-12",
                    "publication_name": {
                        "en": "JOURNAL OF GENE MEDICINE"
                    },
                    "volume": "12",
                    "number": "12",
                    "starting_page": "1030",
                    "ending_page": "1030",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "summary_international_conference",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "1099-498X"
                        ],
                        "wos_id": [
                            "WOS:000285311700045"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000285311700045&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/28946325",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "28946325",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2020-07-11T23:38:12Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T06:58:46Z",
                    "paper_title": {
                        "en": "GENE THERAPY FOR MELANOMA WITH FZ33-ADENOVIRUS AND ANTI-MCSP ANTIBODIES"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Naoya Sakuragi"
                            },
                            {
                                "name": "Kiminori Nakamura"
                            },
                            {
                                "name": "Sachie Hirai"
                            },
                            {
                                "name": "Kazunori Kato"
                            },
                            {
                                "name": "Hirofumi Hamada"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "JOHN WILEY & SONS LTD"
                    },
                    "publication_date": "2010-12",
                    "publication_name": {
                        "en": "JOURNAL OF GENE MEDICINE"
                    },
                    "volume": "12",
                    "number": "12",
                    "starting_page": "1055",
                    "ending_page": "1056",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "misc_type": "summary_international_conference",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "1099-498X"
                        ],
                        "wos_id": [
                            "WOS:000285311700107"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000285311700107&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198300",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198300",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:22Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-11T07:07:22Z",
                    "paper_title": {
                        "en": "ファイバー変異型アデノウイルスベクターを用いたメラノーマ標的化抗体の探索(Screening of melanoma-targetable molecules using a fiber-modified adenoviral vector)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2010-08",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "69回",
                    "starting_page": "319",
                    "ending_page": "319",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2013263907"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/misc/36198299",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/read0019681/misc",
                    "rm:id": "36198299",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2022-01-11T07:07:22Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2023-10-20T06:21:51Z",
                    "paper_title": {
                        "en": "スーパー標的抗体を用いたimmunotoxinの開発 非小細胞肺癌に対する抗TROP2抗体を用いた抗腫瘍活性(Generation of immunotoxins with super-targeting mAb: superior antitumor activities with anti-TROP2 mAb against NSCLC)"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "濱田 洋文"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "(一社)日本癌学会"
                    },
                    "publication_date": "2010-08",
                    "publication_name": {
                        "en": "日本癌学会総会記事"
                    },
                    "volume": "69回",
                    "starting_page": "440",
                    "ending_page": "440",
                    "languages": [
                        "eng"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0546-0476"
                        ],
                        "jamas_id": [
                            "2013264464"
                        ]
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0019681/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 3,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/association_memberships/1637305",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0019681/association_memberships",
                    "rm:id": "1637305",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-07T11:52:07Z",
                    "academic_society_name": {
                        "ja": "日本癌学会",
                        "en": "Japanese Cancer Association"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/association_memberships/1637304",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0019681/association_memberships",
                    "rm:id": "1637304",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-07T11:52:29Z",
                    "academic_society_name": {
                        "ja": "日本薬学会",
                        "en": "The Pharmaceutical Society of Japan"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/read0019681/association_memberships/1637303",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/read0019681/association_memberships",
                    "rm:id": "1637303",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "1000052961",
                    "rm:creator_type": "myself",
                    "rm:created": "2011-05-11T15:00:00Z",
                    "rm:modifier_id": "1000052961",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2022-01-07T11:53:13Z",
                    "academic_society_name": {
                        "ja": "日本生化学会",
                        "en": "The Japanese Biochemical Society"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/read0019681/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/read0019681",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/read0019681/research_projects/45324234",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/read0019681/research_projects",
                    "rm:id": "45324234",
                    "rm:user_id": "1000052961",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-01-30T21:25:12Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-01-30T21:25:12Z",
                    "research_project_title": {
                        "ja": "高性能イミュノトキシンを用いた急性骨髄性白血病の標的化治療",
                        "en": "Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia"
                    },
                    "investigators": {
                        "ja": [
                            {
                                "name": "山口 美樹"
                            },
                            {
                                "name": "濱田 洋文"
                            },
                            {
                                "name": "平井 幸恵"
                            },
                            {
                                "name": "内田 宏昭"
                            }
                        ],
                        "en": [
                            {
                                "name": "YAMAGUCHI MIKI"
                            },
                            {
                                "name": "HAMADA Hirofumi"
                            },
                            {
                                "name": "HIRAI Sachie"
                            },
                            {
                                "name": "UCHIDA Hiroaki"
                            }
                        ]
                    },
                    "offer_organization": {
                        "ja": "日本学術振興会",
                        "en": "Japan Society for the Promotion of Science"
                    },
                    "system_name": {
                        "ja": "科学研究費助成事業",
                        "en": "Grants-in-Aid for Scientific Research"
                    },
                    "category": {
                        "ja": "基盤研究(C)",
                        "en": "Grant-in-Aid for Scientific Research (C)"
                    },
                    "institution_name": {
                        "ja": "札幌医科大学",
                        "en": "Sapporo Medical University"
                    },
                    "from_date": "2011",
                    "to_date": "2013",
                    "overall_grant_amount": {
                        "total_cost": "5200000",
                        "direct_cost": "4000000",
                        "indirect_cost": "1200000"
                    },
                    "description": {
                        "ja": "私たちはジフテリア毒素(DT)とプロテインG(3C)を含むリコンビナントタンパクであるDT3Cを開発した。DT3Cとモノクローナル抗体(MoAb)の結合は容易でありMoAb-DT3C結合体は表面抗原に結合し細胞内へ移行することで殺細胞効果を示す。この系を応用した選択法で腫瘍細胞に特異的なMoAbの樹立が可能であり、私たちは224個のMoAbを樹立した。これらのMoAbはいずれも高いイミュノトキシン活性を示し、抗体薬候補分子に対する抗体が多く含まれていた。また、現在標的治療薬として開発中の抗体が多く含まれており、この方法が抗体薬物複合体(ADC)治療に有効な抗体の選別法であることが示された。",
                        "en": "We generated a recombinant fusion protein DT3C, which contained the catalytic and translocation domain of the truncated diphtheria toxin (DT) as well as the three IgG-binding C domains of streptococcal protein G (3C). Fc of MoAb binds with DT3C, resulting in a MoAb-DT3C complex (two DT3C molecules conjugated with one IgG molecule). The MoAb-DT3C complex binds with the surface Ag, being followed by internalization and translocation into the cytoplasm, leads to the cytocydal effect by protein synthesis inhibition of DT. By using these, we developed a unique screening system to establish cancer-targetable antigens/antibodies sets. In total 224 MoAb clones were obtained which performed immunotoxin cytocydal on leukemic cells. Our method provide an excellent way to obtain promising superior mAbs for antibodies drug conjugation(ADC) therapy."
                    },
                    "identifiers": {
                        "grant_number": [
                            "23501309"
                        ],
                        "national_grant_number": [
                            "JP23501309"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "kaken",
                            "@id": "https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23501309"
                        }
                    ]
                }
            ]
        }
    ]
}